Cocci of Medical Importance .

Uploaded on:
2. General Characteristics of the Staphylococci. Circular cells orchestrated in sporadic clustersGram positive Common tenant of the skin
Slide 1

Cocci of Medical Importance

Slide 2

General Characteristics of the Staphylococci Spherical cells organized in unpredictable groups Gram positive Common tenant of the skin & mucous films Lack spores and flagella May have containers 31 species

Slide 3

Staphylococcus aureus Grows in extensive, round, misty states Optimum temperature of 37 o C Facultative anaerobe Withstands high salt, extremes in pH, & high temperatures Produces numerous harmfulness elements

Slide 4

S. aureus

Slide 5

Enzymes of S. aureus Coagulase – coagulates plasma and blood; created by 97% of human disconnects; analytic Hyaluronidase Staphylokinase DNase Lipases - upgrade colonization on skin Penicillinase (extremely normal)

Slide 6

Toxins of S. aureus Hemolysins – lyse RBCs; α , β , γ , δ Leukocidin Enterotoxins Exfoliative poison Toxic stun disorder poison

Slide 7

S. aureus

Slide 8

S. aureus Present in many situations frequented by people Readily disconnected from fomites Carriage rate for sound grown-ups is 20-60% Carriage is for the most part in front nares, skin, nasopharynx, digestive tract Increase in group obtained methicillin resistance - MRSA

Slide 9

S. aureus maladies Ranges from limited to systemic Localized - boil, folliculitis, furuncle, carbuncle, impetigo Systemic – osteomyelitis, bacteremia Toxigenic ailment – nourishment inebriation, burnt skin disorder, poisonous stun disorder

Slide 10

Clinical concerns 95% have penicillinase & are impervious to penicillin & ampicillin Abscesses must be surgically punctured Systemic diseases require concentrated protracted treatment

Slide 11

Prevention of Staphylococcal Infections Universal safety measures by social insurance suppliers to anticipate nosocomial contaminations Hygiene and purging

Slide 12

Streptococci Gram-positive round/ovoid cocci masterminded in long chains Can shape containers & sludge layers Facultative anaerobes Do not frame catalase, but rather have a peroxidase framework Most parasitic structures are particular & require improved media Sensitive to drying, warm & disinfectants 25 species

Slide 13


Slide 14

Streptococci Lancefield characterization framework in light of cell divider Ag – 14 bunches (A,B,C,… .) Another grouping framework depends on hemolysis responses β - hemolysis – A,B,C,G & some D strains α –hemolysis – S. pneumoniae & others on the whole called viridans

Slide 16

Human Streptococcal Pathogens S. pyogenes S. agalactiae viridans streptococci S. pneumoniae Enterococcus faecalis

Slide 17

β - hemolytic S. pyogenes Most genuine streptococcal pathogen Strict parasite Inhabits throat, nasopharynx, once in a while skin Produces C-sugars, M-protein (fimbrae), streptokinase, hyaluronidase, DNase, hemolysins (SLO, SLS), erythrogenic poison

Slide 19

S. pyogenes Humans are just repository Transmission – contact, beads, nourishment, fomites Skin diseases – impetigo, erysipelas Pharyngitis– strep throat Systemic contaminations: red fever

Slide 20

Long-Term Complications of Group An Infections Rheumatic fever – takes after obvious or subclinical pharyngitis in kids; carditis with broad valve harm conceivable, joint pain, chorea, fever Acute glomerulonephritis – nephritis, expanded circulatory strain, every so often heart disappointment; can get to be distinctly incessant prompting to kidney disappointment

Slide 21

Group B: S. agalactiae Regularly lives in human vagina, pharynx & internal organ Can be exchanged to baby amid conveyance & cause extreme contamination Most pervasive reason for neonatal pneumonia, sepsis, & meningitis 15,000 diseases & 5,000 passings in US Pregnant ladies ought to be screened & treated Wound and skin diseases & endocarditis in incapacitated individuals

Slide 22

Group D Enterococci and Groups C and G Streptococci Group D: Enterococcus faecalis, E. faecium, E. durans Normal pilgrims of human digestive organ Cause pioneering urinary, injury, and skin diseases, especially in weakened people Groups C and G: Common creature greenery, much of the time disengaged from upper respiratory tract; pharyngitis, glomerulonephritis, bacteremia

Slide 23

Clinical Considerations Group A & B are treated with penicillin Enterococci typically treated with ampicillin and gentamicin No immunizations accessible

Slide 24

Viridans gather α - hemolytic Large complex gathering (ex. S. mutans ) Most various & far reaching inhabitants of the oral cavity & additionally found in nasopharynx, genital tract, skin Not extremely obtrusive, dental or surgical methodology encourage entrance

Slide 25

Viridans Group Bacteremia, meningitis, stomach contamination, tooth abscesses Most genuine contamination – subacute endocarditis – blood-borne microbes settle & develop on heart fixing or valves Persons with prior coronary illness are at high hazard & get prophylactic anti-infection agents before surgery or dental systems

Slide 26

S. pneumoniae Causes 60-70% of every single bacterial pneumonia Small, lancet-molded cells organized in sets and short chains Culture requires blood or chocolate agar Growth enhanced by 5-10% CO 2 Lack catalase & peroxidases – societies kick the bucket in O 2

Slide 28

S. pneumoniae All pathogenic strains frame vast containers – real harmfulness calculate Specific solvent substance (SSS) differs among sorts 84 capsular sorts have been distinguished utilizing Quellung test or capsular swelling response Causes pneumonia & otitis media

Slide 29

S. pneumoniae

Slide 30

S. pneumoniae 5-half surprisingly convey it as typical greenery in pharynx Very sensitive, does not survive long outside of its territory Pneumonia happens when cells are suctioned into the lungs of helpless people Pneumococci duplicate & initiate a mind-boggling provocative reaction

Slide 31

Treatment and Prevention Traditionally treated with penicillin G or V Increased medication resistance Two antibodies accessible for high hazard people: capsular antigen immunization for more established grown-ups and other high hazard people successful 5 years conjugate immunization for youngsters 2 to 23 months

View more...